Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC / Nga mice
- 16 March 2011
- journal article
- Published by Wiley in Journal of Applied Microbiology
- Vol. 110 (5), 1195-1202
- https://doi.org/10.1111/j.1365-2672.2011.04981.x
Abstract
Atopic dermatitis (AD) is marked by elevated levels of immunoglobulin E and skin lesions such as oedema and haemorrhage. Kimchi is a Korean fermented food that contains beneficial bacteria for human health. In this study, Lactobacillus plantarum CJLP55, CJLP56, CJLP133 and CJLP136 isolated from Kimchi were investigated for their capacity to inhibit AD. The three strains, CJLP55, CJLP133 and CJLP136, suppressed AD-like skin lesions, high serum IgE levels and epidermal thickening. The three strains diminished the accumulation of eosinophils and mast cells into topical inflammatory sites and the enlargement of axillary lymph nodes, which are responsible for the dorsal dermatitis. CJLP55, CJLP133 and CJLP136 decreased production of type 2 cytokines such as IL-4 and IL-5 in lymph node cell culture. CJLP133 and CJLP136 increased IFN-γ secretion, while CJLP55 enhanced IL-10 production. The three strains isolated from Kimchi suppress house-dust mite-induced dermatitis in NC/Nga mouse, a representative animal model of human AD. These findings suggest that lactobacilli isolated from Kimchi inhibit AD, probably by altering the balance of Th1/Th2 ratio or inducing IL-10 production.Keywords
This publication has 22 references indexed in Scilit:
- Bacterial strain‐specific induction of Foxp3+ T regulatory cells is protective in murine allergy modelsClinical and Experimental Allergy, 2010
- A Novel Probiotic Mixture Exerts a Therapeutic Effect on Experimental Autoimmune Encephalomyelitis Mediated by IL-10 Producing Regulatory T CellsPLOS ONE, 2010
- Induction of Th1 cytokines by Leuconostoc mesenteroides subsp. mesenteroides (KCTC 3100) under Th2-type conditions and the requirement of NF-κB and p38/JNKCytokine, 2009
- Leuconostoc citreum HJ‐P4 (KACC 91035) regulates immunoglobulin E in an ovalbumin‐induced allergy model and induces interleukin‐12 through nuclear factor‐kappa B and p38/c‐Jun N‐terminal kinases signaling in macrophagesMicrobiology and Immunology, 2009
- Inhibition of atopic dermatitis by topical application of silymarin in NC/Nga miceInternational Immunopharmacology, 2008
- Inhibition of atopic dermatitis‐like skin lesions by topical application of a novel ceramide derivative, K6PC‐9p, in NC/Nga miceExperimental Dermatology, 2008
- Primary administration ofLactobacillus johnsoniiNCC533 in weaning period suppresses the elevation of proinflammatory cytokines and CD86 gene expressions in skin lesions in NC/Nga miceFEMS Immunology & Medical Microbiology, 2007
- Induction of atopic eczema/dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC/Nga miceInternational Immunopharmacology, 2006
- Establishment of Allergic Dermatitis in NC/Nga Mice as a Model for Severe Atopic DermatitisBiological & Pharmaceutical Bulletin, 2004
- A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house‐dust mite Dermatophagoides farinaeAllergy, 2003